Progressive Increase in Small Intestinal Bacterial Overgrowth Risk Following COVID-19 Infection: A Global Population-Based Study
COVID-19 significantly increased the risk of SIBO, particularly within the first 12 months post-infection, across various age groups and, notably, in association with certain chronic medications. Clinical vigilance and targeted management strategies are recommended to mitigate long-term GI consequences.
Authors
- Gengqing Song (ORCID: https://orcid.org/0000-0001-5551-1818)
- Tao Bai (ORCID: https://orcid.org/0000-0001-9697-8510)
- Yilin Song (ORCID: https://orcid.org/0000-0002-9664-2029)
- Linda L. D. Zhong (ORCID: https://orcid.org/0000-0002-3877-1914)
- Benjamin D. Liu (ORCID: https://orcid.org/0000-0002-2089-7607)
- Thai Hau Koo (ORCID: https://orcid.org/0009-0003-6671-0929)
- Lei Tu (ORCID: https://orcid.org/0000-0002-1475-2858)
- Xiaohua Hou
Institutions
- University of Maryland, Baltimore (US)
- Union Hospital (HK)
- Mayo Clinic (US)
- Nanyang Technological University (SG)
- Hospital Universiti Sains Malaysia (MY)
- Mayo Clinic in Arizona (US)
- University of Maryland Medical Center Midtown Campus (US)
- Mayo Clinic in Florida (US)
- MetroHealth Medical Center (US)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Diseases
- Published
- 2025-08-22
- DOI
- https://doi.org/10.3390/diseases13090275
- Primary Topic
- Gastrointestinal motility and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00